0.1(top 100%)
impact factor
325(top 50%)
papers
139(top 50%)
citations
4(top 100%)
h-index
0.1(top 100%)
extended IF
381
all documents
204
doc citations
6(top 100%)
g-index
Top Articles
| # | Title | Journal | Year | Citations |
|---|---|---|---|---|
| 1 | Natural History of Treated and Untreated Hypertension | Updates in Hypertension and Cardiovascular Protection | 2018 | 6 |
| 2 | Drug Adherence in Hypertension and Cardiovascular Protection | Updates in Hypertension and Cardiovascular Protection | 2018 | 5 |
| 3 | Beliefs and Adherence in Hypertension and Cardiovascular Protection | Updates in Hypertension and Cardiovascular Protection | 2018 | 5 |
| 4 | Stress and Hypertension | Updates in Hypertension and Cardiovascular Protection | 2018 | 4 |
| 5 | Directly Observed Therapy in Hypertension (DOT-HTN) | Updates in Hypertension and Cardiovascular Protection | 2018 | 4 |
| 6 | Measurements of Antihypertensive Medications in Blood and Urine | Updates in Hypertension and Cardiovascular Protection | 2018 | 4 |
| 7 | Hypertension and Brain Damage | Updates in Hypertension and Cardiovascular Protection | 2016 | 3 |
| 8 | Taxonomy of Medication Adherence: Recent Developments | Updates in Hypertension and Cardiovascular Protection | 2018 | 3 |
| 9 | Molecular Pathways in Hypertensive Renal Damage | Updates in Hypertension and Cardiovascular Protection | 2018 | 3 |
| 10 | Pathophysiology of Brain Damage in Hypertension: Small Vessel Disease | Updates in Hypertension and Cardiovascular Protection | 2016 | 3 |
| 11 | Obesity and Metabolic Syndrome Hypertension | Updates in Hypertension and Cardiovascular Protection | 2018 | 3 |
| 12 | Migration, Communicable, and Noncommunicable Diseases: Are We Witnessing a Paradigm Shift? | Updates in Hypertension and Cardiovascular Protection | 2018 | 3 |
| 13 | Microvascular Alterations in Diabetes: Focus on Small Resistance Arteries | Updates in Hypertension and Cardiovascular Protection | 2020 | 3 |
| 14 | Interventional Therapies for Secondary and Essential Hypertension | Updates in Hypertension and Cardiovascular Protection | 2016 | 2 |
| 15 | Digital Medicines to Measure Drug Ingestion Adherence | Updates in Hypertension and Cardiovascular Protection | 2018 | 2 |
| 16 | Sympathoadrenal Reactivity to Stress as a Predictor of Cardiovascular Risk Factors | Updates in Hypertension and Cardiovascular Protection | 2019 | 2 |
| 17 | Arterial Stiffness in Early Phases of Prehypertension | Updates in Hypertension and Cardiovascular Protection | 2019 | 2 |
| 18 | Primary Hypertension | Updates in Hypertension and Cardiovascular Protection | 2019 | 2 |
| 19 | Home Blood Pressure Monitoring: Cost-Effectiveness, Patients’ Preference and Barriers for Clinical Use | Updates in Hypertension and Cardiovascular Protection | 2020 | 2 |
| 20 | Comorbidities Often Associated with Brain Damage in Hypertension: Diabetes, Coronary Artery Disease, Chronic Kidney Disease and Obstructive Sleep Apnoea | Updates in Hypertension and Cardiovascular Protection | 2016 | 2 |
| 21 | Prehypertension and the Renin-Angiotensin-Aldosterone System | Updates in Hypertension and Cardiovascular Protection | 2019 | 2 |
| 22 | Qualitative Assessments of Adherence | Updates in Hypertension and Cardiovascular Protection | 2018 | 2 |
| 23 | Ethical Aspects of Measuring Adherence to Antihypertensive Treatment | Updates in Hypertension and Cardiovascular Protection | 2018 | 2 |
| 24 | Pathophysiology of Subclinical Brain Damage in Hypertension: Large Artery Disease | Updates in Hypertension and Cardiovascular Protection | 2016 | 2 |
| 25 | Disorders of Blood Pressure Regulation | Updates in Hypertension and Cardiovascular Protection | 2018 | 2 |
| 26 | Guidelines for Home Blood Pressure Monitoring | Updates in Hypertension and Cardiovascular Protection | 2020 | 2 |
| 27 | Diagnostic Value of Home Blood Pressure | Updates in Hypertension and Cardiovascular Protection | 2020 | 2 |
| 28 | Epidemiology of Hypertension in Asia | Updates in Hypertension and Cardiovascular Protection | 2022 | 2 |
| 29 | Coexistence of Diabetes Mellitus and Hypertension | Updates in Hypertension and Cardiovascular Protection | 2023 | 2 |
| 30 | Primary Aldosteronism: A Field on the Move | Updates in Hypertension and Cardiovascular Protection | 2016 | 1 |
| 31 | Management of High Blood Pressure in Intracerebral Haemorrhage | Updates in Hypertension and Cardiovascular Protection | 2016 | 1 |
| 32 | Hypertension, Cognitive Decline, and Dementia | Updates in Hypertension and Cardiovascular Protection | 2016 | 1 |
| 33 | Diagnostic and Prognostic Significance of Blood Pressure Indices | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |
| 34 | Vasoactive Peptides | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |
| 35 | Endothelial Function | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |
| 36 | The Kidneys, Volume and Blood Pressure Regulation, and Hypertension | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |
| 37 | Causes of Secondary Hypertension in Children and Adolescents | Updates in Hypertension and Cardiovascular Protection | 2019 | 1 |
| 38 | Treatment of Hypertension in Chronic Kidney Disease | Updates in Hypertension and Cardiovascular Protection | 2019 | 1 |
| 39 | Natriuretic Peptides | Updates in Hypertension and Cardiovascular Protection | 2019 | 1 |
| 40 | Role of Central Blood Pressure and Arterial Stiffening | Updates in Hypertension and Cardiovascular Protection | 2019 | 1 |
| 41 | Home Blood Pressure Monitoring in Prehypertension and Hypertension | Updates in Hypertension and Cardiovascular Protection | 2019 | 1 |
| 42 | High-Normal Blood Pressure in Children and Adolescents | Updates in Hypertension and Cardiovascular Protection | 2019 | 1 |
| 43 | Prehypertension and Cardiometabolic Syndrome | Updates in Hypertension and Cardiovascular Protection | 2019 | 1 |
| 44 | Secondary Hypertension | Updates in Hypertension and Cardiovascular Protection | 2020 | 1 |
| 45 | Familial Hyperaldosteronism | Updates in Hypertension and Cardiovascular Protection | 2020 | 1 |
| 46 | Carotid Baroreceptor Stimulation | Updates in Hypertension and Cardiovascular Protection | 2016 | 1 |
| 47 | Perioperative Cardiac Surgery Hypertension | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |
| 48 | Cushing’s Syndrome and Glucocorticoid Excess | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |
| 49 | Secondary Hypertension: Infrequently Considered Aspects—Illicit/Recreational Substances, Herbal Remedies, and Drug-Associated Hypertension | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |
| 50 | Hormonal Systems | Updates in Hypertension and Cardiovascular Protection | 2018 | 1 |